Myeloma2018 Session VI

 

Microenvironment

During session VI at Myeloma2018, Kyohei Nakamura, MD, PhD, Bruno Paiva, PhD, and Marta Chesi, PhD, present stimulating evidence of the role the immune microenvironment plays in MM progression.
Key questions are asked on how understanding tumor-promoting inflammation could potentially present opportunities for therapeutic targeting, and how a mouse model of human cereblon could be useful in predicting survival outcomes from immunomodulatory drug treatment in MM.

Presentations
Inflammation and Immunosuppression in the Myeloma Microenvironment
Kyohei Nakamura, MD, PhD
QIMR Berghofer Medical Research Institute, Brisbane, Australia
8 September, 2018

Kyohei Nakamura, MD, PhD, from the QIMR Berghofer Medical Research Institute, Brisbane, Australia, discusses the microenvironment in myeloma.

Immune Microenvironment
Bruno Paiva, PhD
University of Navarra, Pamplona, Spain
8 September, 2018

Bruno Paiva, PhD, from the University of Navarra, Pamplona, Spain, talks about the immune microenvironment.

Optimizing Immunotherapy in Multiple Myeloma
Marta Chesi, PhD
Mayo Clinic, Scottsdale, AZ
8 September, 2018

Marta Chesi, PhD, from the Clinic, Scottsdale, AZ, explores optimizing immunotherapy in multiple myeloma.